Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
3bHFhgQUbgShwAkj
Français